$75.99
11.1917.27%
Last update: Nov 6, 7:29 PM
CG Oncology Inc
CGONNASDAQ
The average analyst price target for CG Oncology is $71.94, 5.4% below the current price. Of 16 analysts, 15 rate it Buy and 1 Hold. Targets range from $23 to $100. The latest change came on Aug 7, 2026, when RBC Capital lowered its price target on CG Oncology from $81 to $79 and kept an Outperform rating.
Price Target Range — 11 Quarters
Analyst Consensus — 16 Analysts
Rating Trend — Last 9 Months
